Skip to content

Imprint Pharmaceuticals Limited

United KingdomFDA applicant, unverified

Devices
2

What Imprint Pharmaceuticals Limited makes

Imprint Pharmaceuticals Limited produces DEPOTONE, which is listed as a Class II medical device.

The company is based in the US and its devices are listed in the FDA 510(k) registry.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

  • Depotone Ref K050505

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Depotone Ref K061032

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Imprint Pharmaceuticals Limited have in the registry?

The registry currently lists 2 devices for Imprint Pharmaceuticals Limited. Devices recorded under merged duplicate company entries are counted once.

Which registries list Imprint Pharmaceuticals Limited's devices?

Among its 2 most recently registered devices, Imprint Pharmaceuticals Limited has devices listed in FDA 510(k) (2 devices).

What risk classes do Imprint Pharmaceuticals Limited's devices fall under?

Among its 2 most recently registered devices, the classes recorded for Imprint Pharmaceuticals Limited's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Imprint Pharmaceuticals Limited in the registry?

The most recently registered devices listed for Imprint Pharmaceuticals Limited include DEPOTONE.

Generated automatically from registry data and not verified by a human reviewer.